# Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

> **NCT01571063** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 22 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis (NASH)

## Interventions

- **DRUG:** Vitamin D3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01571063
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2016-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01571063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01571063, "Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01571063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*